1. Academic Validation
  2. Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro

Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro

  • Cancer Res. 2003 Jan 1;63(1):22-4.
Jae Wan Lee 1 Steven M Yannone David J Chen Lawrence F Povirk
Affiliations

Affiliation

  • 1 Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298, USA.
PMID: 12517771
Abstract

In the nonhomologous end joining pathway of DNA double-strand break repair, the ligation step is catalyzed by a complex of XRCC4 and DNA Ligase IV. Extracts of CHO-K1 cells are able to accurately rejoin a site-specific free radical-mediated double-strand break with partially complementary overhangs, by a mechanism involving alignment-based gap filling followed by ligation. Extracts of XR-1 cells, which lack XRCC4 and DNA Ligase IV, carried out neither gap filling nor ligation. Supplementation of the extracts with recombinant XRCC4/Ligase IV, but not with XRCC4 alone, restored gap filling and accurate end joining. The results imply that XRCC4 and Ligase IV are essential for alignment-based gap filling, as well as for final ligation of the breaks.

Figures